The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Phase I study of a novel S1P inhibitor, NOX66, in combination with radiotherapy in patients with metastatic castration-resistant prostate cancer.

Paul L.  de Souza

Consulting or Advisory Role - Biosceptre International

Anne Louise  Capp

Employment - Genesis Cancer Care

Stock and Other Ownership Interests  - GenesisCare

Consulting or Advisory Role - Noxopharm

Research Funding - Noxopharm

Nana  Chikhladze

Research Funding - Noxopharm (Inst)

Zaza  Mezvrishvili

Research Funding - Noxopharm (Inst)

Marinella  Messina

Employment - Noxopharm

Gisela  Mautner

Employment - Noxopharm